Garnier, M.; Sabbah, M.; Ménager, C.; Griffete, N. Hybrid Molecularly Imprinted Polymers: The Future of Nanomedicine? Nanomaterials2021, 11, 3091.
Garnier, M.; Sabbah, M.; Ménager, C.; Griffete, N. Hybrid Molecularly Imprinted Polymers: The Future of Nanomedicine? Nanomaterials 2021, 11, 3091.
Garnier, M.; Sabbah, M.; Ménager, C.; Griffete, N. Hybrid Molecularly Imprinted Polymers: The Future of Nanomedicine? Nanomaterials2021, 11, 3091.
Garnier, M.; Sabbah, M.; Ménager, C.; Griffete, N. Hybrid Molecularly Imprinted Polymers: The Future of Nanomedicine? Nanomaterials 2021, 11, 3091.
Abstract
Molecularly imprinted polymers (MIPs) have been widely used in nanomedicine during the last few years. However, their potential is limited by their intrinsic properties resulting, for instance, in lack of control in drug release processes or complex detection for in vivo imaging. Recent attempts in creating hybrid nanomaterials combining MIPs with inorganic nanomaterials succeeded in providing a wide range of new interesting properties suitable for nanomedicine. Through this review, we aim to illustrate how hybrids molecularly imprinted polymers may improve patient care with enhanced imaging, treatments and combination of both.
Keywords
Nanomedicine; molecularly imprinted polymer; drug delivery; targeting; hybrid material
Subject
Chemistry and Materials Science, Polymers and Plastics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.